red blood cells
| 10+ min read
For decades, treatment options for sickle cell disease have been extremely limited. Soon, gene therapies and a host of pharmaceuticals could alleviate the immense burden of this disease.
| 2 min read
A coordinated effort between the stroma, the immune system, and the skin microbiome restores damaged skin.
Available on Demand
Innovative carriers and delivery strategies may improve gene therapy efficacy and safety.
| 10+ min read
Alpha thalassemia was once a fatal diagnosis. Now, a clinical trial tests if administering a mother’s stem cells in utero may cure kids before they’re born.
| 10+ min read
Facing donor shortages and storage limitations, researchers are developing synthetic red blood cells, platelets, and plasma and combining them into artificial blood.
| 6 min read
Red blood cells may play a role in COVID-19 and other infections.
| 4 min read
When a research question can’t be answered using the tools available, bioengineer Kiana Aran makes new tools. Recently, she developed a new type of brain-on-a-chip to answer questions about the blood brain barrier.
| 4 min read
New technology turns red blood cells into artificial antigen-presenting cells. These cells activate T cells to attack HPV-driven cancers.
Page 1 of 1 - 8 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Supercharging cell line development and engineering with automated single cell sorting
Researchers can enhance efficiency, yield, and consistency in clonal cell line development with specialized tools.
